4503 — Astellas Pharma Income Statement
0.000.00%
Last trade - 00:00HealthcareConservativeLarge CapHigh Flyer
- ¥4tn
- ¥4tn
- ¥2tn
- 98
- 30
- 72
- 78
Annual income statement for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,306,348 | 1,300,843 | 1,249,528 | 1,296,163 | 1,518,619 |
| Cost of Revenue | |||||
| Gross Profit | 1,014,298 | 1,024,104 | 1,003,465 | 1,043,154 | 1,230,266 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,062,436 | 1,056,852 | 1,102,919 | 1,135,393 | 1,385,590 |
| Operating Profit | 243,912 | 243,991 | 146,609 | 160,770 | 133,029 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 248,967 | 245,350 | 145,324 | 156,886 | 132,361 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 222,265 | 195,411 | 120,590 | 124,086 | 98,714 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 222,265 | 195,411 | 120,590 | 124,086 | 98,714 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 222,265 | 195,411 | 120,589 | 124,086 | 98,714 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 135 | 110 | 111 | 95.3 | 54.2 |
| Dividends per Share |